Benign and malignant thyroid diseases (TDs) have been associated with the occurrence of extrathyroidal malignancies (EMs), including colorectal cancers (CRCs). Such associations have generated a major interest, as their characterization may provide useful clues regarding diseases’ etiology and/or progression, with the possible identification of shared congenital and environmental elements. On the other hand, elucidation of the underlying molecular mechanism(s) could lead to an improved and tailored clinical management of these patients and stimulate an increased surveillance of TD patients at higher threat of developing EMs. Here, we will examine the epidemiological, clinical, and molecular findings connecting TD and CRC, with the aim to identify possible molecular mechanism(s) responsible for such diseases’ relationship.
Insights on the association between thyroid diseases and colorectal cancer / Gagliardi, Federica; Baldini, Enke; Lori, Eleonora; Cardarelli, Silvia; Pironi, Daniele; Lauro, Augusto; Tripodi, Domenico; Palumbo, Piergaspare; D'Armiento, Eleonora; Cavallaro, Giuseppe; Polistena, Andrea; D'Orazi, Valerio; Sibio, Simone; Fallahi, Poupak; Antonelli, Alessandro; D'Andrea, Vito; Ulisse, Salvatore; Sorrenti, Salvatore. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 12:6(2023). [10.3390/jcm12062234]
Insights on the association between thyroid diseases and colorectal cancer
Federica GagliardiCo-primo
;Enke BaldiniCo-primo
;Eleonora LoriSecondo
;Silvia Cardarelli;Daniele Pironi;Augusto Lauro;Domenico Tripodi;Piergaspare Palumbo;Eleonora D’Armiento;Giuseppe Cavallaro;Andrea Polistena;Valerio D'Orazi;simone sibio;Alessandro Antonelli;VITO D'ANDREA;Salvatore Ulisse
Penultimo
;Salvatore SORRENTIUltimo
2023
Abstract
Benign and malignant thyroid diseases (TDs) have been associated with the occurrence of extrathyroidal malignancies (EMs), including colorectal cancers (CRCs). Such associations have generated a major interest, as their characterization may provide useful clues regarding diseases’ etiology and/or progression, with the possible identification of shared congenital and environmental elements. On the other hand, elucidation of the underlying molecular mechanism(s) could lead to an improved and tailored clinical management of these patients and stimulate an increased surveillance of TD patients at higher threat of developing EMs. Here, we will examine the epidemiological, clinical, and molecular findings connecting TD and CRC, with the aim to identify possible molecular mechanism(s) responsible for such diseases’ relationship.File | Dimensione | Formato | |
---|---|---|---|
Gagliardi_Insights_2023.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
604.27 kB
Formato
Adobe PDF
|
604.27 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.